Inflammatory bowel disease risk in patients with axial spondyloarthritis treated with biologic agents : Determined Using the BSRBR-AS and a MetaAnalysis
Publication date
02/2023Metadata
Show full item recordCitation
Macfarlane , G , Biallas , R , Dean , LE , Jones , GT , Goodson , N J & Rotariu , O 2023 , ' Inflammatory bowel disease risk in patients with axial spondyloarthritis treated with biologic agents : Determined Using the BSRBR-AS and a MetaAnalysis ' , Journal of Rheumatology , vol. 50 , no. 2 , pp. 175-184 . https://doi.org/10.3899/jrheum.211034
Rights
This is a pre-copyediting, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxx [insert URL for fully published article in The Journal of Rheumatology website].